Clot Management Device - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509251220

Publication Date:

September 11, 2024

Pages:

142

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Clot Management Device was estimated to be worth US$ 1339.4 million in 2023 and is forecast to a readjusted size of US$ 1986.9 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clot Management Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Clot Management Device by region & country, by Type, and by Application.
The Clot Management Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clot Management Device.
麻豆原创 Segmentation
By Company
Edwards Lifesciences
Boston Scientific
AngioDynamics
Cook
Acandis
Stryker
Covidien(Medtronic)
Argon
Asid Bonz
DePuy Synthes
Biosensors
Dispomedica
IVascular
Eurocor
Teleflex
LeMaitre Vascular
Phenox
Merit Medical
Segment by Type:
Inferior Vena Cava Filters(IVCF)
Neurovascular Embolectomy Devices
Catheter-Directed Thrombolysis(CDT) Devices
Percutaneous Thrombectomy Devices
Embolectomy Balloon Catheters/Clot Management Catheter
Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clot Management Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Clot Management Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Clot Management Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Clot Management Device Product Introduction
1.2 Global Clot Management Device 麻豆原创 Size Forecast
1.2.1 Global Clot Management Device Sales Value (2019-2030)
1.2.2 Global Clot Management Device Sales Volume (2019-2030)
1.2.3 Global Clot Management Device Sales Price (2019-2030)
1.3 Clot Management Device 麻豆原创 Trends & Drivers
1.3.1 Clot Management Device Industry Trends
1.3.2 Clot Management Device 麻豆原创 Drivers & Opportunity
1.3.3 Clot Management Device 麻豆原创 Challenges
1.3.4 Clot Management Device 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clot Management Device Players Revenue Ranking (2023)
2.2 Global Clot Management Device Revenue by Company (2019-2024)
2.3 Global Clot Management Device Players Sales Volume Ranking (2023)
2.4 Global Clot Management Device Sales Volume by Company Players (2019-2024)
2.5 Global Clot Management Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Clot Management Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Clot Management Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Clot Management Device
2.9 Clot Management Device 麻豆原创 Competitive Analysis
2.9.1 Clot Management Device 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Clot Management Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clot Management Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Inferior Vena Cava Filters(IVCF)
3.1.2 Neurovascular Embolectomy Devices
3.1.3 Catheter-Directed Thrombolysis(CDT) Devices
3.1.4 Percutaneous Thrombectomy Devices
3.1.5 Embolectomy Balloon Catheters/Clot Management Catheter
3.2 Global Clot Management Device Sales Value by Type
3.2.1 Global Clot Management Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clot Management Device Sales Value, by Type (2019-2030)
3.2.3 Global Clot Management Device Sales Value, by Type (%) (2019-2030)
3.3 Global Clot Management Device Sales Volume by Type
3.3.1 Global Clot Management Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Clot Management Device Sales Volume, by Type (2019-2030)
3.3.3 Global Clot Management Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Clot Management Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Center
4.1.3 Diagnostic Center
4.2 Global Clot Management Device Sales Value by Application
4.2.1 Global Clot Management Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clot Management Device Sales Value, by Application (2019-2030)
4.2.3 Global Clot Management Device Sales Value, by Application (%) (2019-2030)
4.3 Global Clot Management Device Sales Volume by Application
4.3.1 Global Clot Management Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Clot Management Device Sales Volume, by Application (2019-2030)
4.3.3 Global Clot Management Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Clot Management Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Clot Management Device Sales Value by Region
5.1.1 Global Clot Management Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clot Management Device Sales Value by Region (2019-2024)
5.1.3 Global Clot Management Device Sales Value by Region (2025-2030)
5.1.4 Global Clot Management Device Sales Value by Region (%), (2019-2030)
5.2 Global Clot Management Device Sales Volume by Region
5.2.1 Global Clot Management Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Clot Management Device Sales Volume by Region (2019-2024)
5.2.3 Global Clot Management Device Sales Volume by Region (2025-2030)
5.2.4 Global Clot Management Device Sales Volume by Region (%), (2019-2030)
5.3 Global Clot Management Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Clot Management Device Sales Value, 2019-2030
5.4.2 North America Clot Management Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Clot Management Device Sales Value, 2019-2030
5.5.2 Europe Clot Management Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Clot Management Device Sales Value, 2019-2030
5.6.2 Asia Pacific Clot Management Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Clot Management Device Sales Value, 2019-2030
5.7.2 South America Clot Management Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Clot Management Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Clot Management Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clot Management Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clot Management Device Sales Value
6.2.1 Key Countries/Regions Clot Management Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Clot Management Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Clot Management Device Sales Value, 2019-2030
6.3.2 United States Clot Management Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clot Management Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clot Management Device Sales Value, 2019-2030
6.4.2 Europe Clot Management Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clot Management Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clot Management Device Sales Value, 2019-2030
6.5.2 China Clot Management Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clot Management Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clot Management Device Sales Value, 2019-2030
6.6.2 Japan Clot Management Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clot Management Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clot Management Device Sales Value, 2019-2030
6.7.2 South Korea Clot Management Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clot Management Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clot Management Device Sales Value, 2019-2030
6.8.2 Southeast Asia Clot Management Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clot Management Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clot Management Device Sales Value, 2019-2030
6.9.2 India Clot Management Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clot Management Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Edwards Lifesciences
7.1.1 Edwards Lifesciences Company Information
7.1.2 Edwards Lifesciences Introduction and Business Overview
7.1.3 Edwards Lifesciences Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Edwards Lifesciences Clot Management Device Product Offerings
7.1.5 Edwards Lifesciences Recent Development
7.2 Boston Scientific
7.2.1 Boston Scientific Company Information
7.2.2 Boston Scientific Introduction and Business Overview
7.2.3 Boston Scientific Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boston Scientific Clot Management Device Product Offerings
7.2.5 Boston Scientific Recent Development
7.3 AngioDynamics
7.3.1 AngioDynamics Company Information
7.3.2 AngioDynamics Introduction and Business Overview
7.3.3 AngioDynamics Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AngioDynamics Clot Management Device Product Offerings
7.3.5 AngioDynamics Recent Development
7.4 Cook
7.4.1 Cook Company Information
7.4.2 Cook Introduction and Business Overview
7.4.3 Cook Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cook Clot Management Device Product Offerings
7.4.5 Cook Recent Development
7.5 Acandis
7.5.1 Acandis Company Information
7.5.2 Acandis Introduction and Business Overview
7.5.3 Acandis Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Acandis Clot Management Device Product Offerings
7.5.5 Acandis Recent Development
7.6 Stryker
7.6.1 Stryker Company Information
7.6.2 Stryker Introduction and Business Overview
7.6.3 Stryker Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Stryker Clot Management Device Product Offerings
7.6.5 Stryker Recent Development
7.7 Covidien(Medtronic)
7.7.1 Covidien(Medtronic) Company Information
7.7.2 Covidien(Medtronic) Introduction and Business Overview
7.7.3 Covidien(Medtronic) Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Covidien(Medtronic) Clot Management Device Product Offerings
7.7.5 Covidien(Medtronic) Recent Development
7.8 Argon
7.8.1 Argon Company Information
7.8.2 Argon Introduction and Business Overview
7.8.3 Argon Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Argon Clot Management Device Product Offerings
7.8.5 Argon Recent Development
7.9 Asid Bonz
7.9.1 Asid Bonz Company Information
7.9.2 Asid Bonz Introduction and Business Overview
7.9.3 Asid Bonz Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Asid Bonz Clot Management Device Product Offerings
7.9.5 Asid Bonz Recent Development
7.10 DePuy Synthes
7.10.1 DePuy Synthes Company Information
7.10.2 DePuy Synthes Introduction and Business Overview
7.10.3 DePuy Synthes Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.10.4 DePuy Synthes Clot Management Device Product Offerings
7.10.5 DePuy Synthes Recent Development
7.11 Biosensors
7.11.1 Biosensors Company Information
7.11.2 Biosensors Introduction and Business Overview
7.11.3 Biosensors Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Biosensors Clot Management Device Product Offerings
7.11.5 Biosensors Recent Development
7.12 Dispomedica
7.12.1 Dispomedica Company Information
7.12.2 Dispomedica Introduction and Business Overview
7.12.3 Dispomedica Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Dispomedica Clot Management Device Product Offerings
7.12.5 Dispomedica Recent Development
7.13 IVascular
7.13.1 IVascular Company Information
7.13.2 IVascular Introduction and Business Overview
7.13.3 IVascular Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.13.4 IVascular Clot Management Device Product Offerings
7.13.5 IVascular Recent Development
7.14 Eurocor
7.14.1 Eurocor Company Information
7.14.2 Eurocor Introduction and Business Overview
7.14.3 Eurocor Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Eurocor Clot Management Device Product Offerings
7.14.5 Eurocor Recent Development
7.15 Teleflex
7.15.1 Teleflex Company Information
7.15.2 Teleflex Introduction and Business Overview
7.15.3 Teleflex Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Teleflex Clot Management Device Product Offerings
7.15.5 Teleflex Recent Development
7.16 LeMaitre Vascular
7.16.1 LeMaitre Vascular Company Information
7.16.2 LeMaitre Vascular Introduction and Business Overview
7.16.3 LeMaitre Vascular Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.16.4 LeMaitre Vascular Clot Management Device Product Offerings
7.16.5 LeMaitre Vascular Recent Development
7.17 Phenox
7.17.1 Phenox Company Information
7.17.2 Phenox Introduction and Business Overview
7.17.3 Phenox Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Phenox Clot Management Device Product Offerings
7.17.5 Phenox Recent Development
7.18 Merit Medical
7.18.1 Merit Medical Company Information
7.18.2 Merit Medical Introduction and Business Overview
7.18.3 Merit Medical Clot Management Device Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Merit Medical Clot Management Device Product Offerings
7.18.5 Merit Medical Recent Development
8 Industry Chain Analysis
8.1 Clot Management Device Industrial Chain
8.2 Clot Management Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clot Management Device Sales Model
8.5.2 Sales Channel
8.5.3 Clot Management Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Edwards Lifesciences
Boston Scientific
AngioDynamics
Cook
Acandis
Stryker
Covidien(Medtronic)
Argon
Asid Bonz
DePuy Synthes
Biosensors
Dispomedica
IVascular
Eurocor
Teleflex
LeMaitre Vascular
Phenox
Merit Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.